Henry Chen
Directeur Général chez Curamir Therapeutics, Inc.
Profil
Henry Chen is the founder and currently serves as the Managing Partner at Delos Advisors Ltd., a company he founded in 2014.
He is also the founder and Chief Executive Officer of Curamir Therapeutics, Inc., which is established in 2019.
In addition to his founding positions, Mr. Chen previously held the role of Chief Executive Officer at Tanvex BioPharma USA, Inc. from 2020 to 2021.
Prior to that, he was a Partner & Co-Head at Permira Advisers (China) Ltd.
from 2008 to 2014.
Mr. Chen obtained his undergraduate degree from Harvard Law School in 1996.
Postes actifs de Henry Chen
| Sociétés | Poste | Début |
|---|---|---|
Curamir Therapeutics, Inc.
 Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Directeur Général | 01/01/2019 |
Delos Advisors Ltd.
 Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Fondateur | 01/12/2014 |
Anciens postes connus de Henry Chen
| Sociétés | Poste | Fin |
|---|---|---|
| Tanvex BioPharma USA, Inc. | Directeur Général | 01/10/2021 |
| Permira Advisers (China) Ltd. | Public Communications Contact | 01/12/2014 |
Formation de Henry Chen
| Harvard Law School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| Tanvex BioPharma USA, Inc. | |
| Permira Advisers (China) Ltd. | Finance |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Advisors Ltd (Delos Capital) is a private equity and venture capital firm founded by Lin Zheng Chen in 2014. The firm is headquartered in Hong Kong. | Finance |
Curamir Therapeutics, Inc.
Curamir Therapeutics, Inc. BiotechnologyHealth Technology Curamir Therapeutics, Inc. engages in the provision of biotechnology company specializing in micro RNA (miRNA) based cancer therapeutics. The company was founded by Henry Chen, Jingfang Ju, James D. Watson, and Lan Bo Chen and is headquartered in Woburn, MA. | Health Technology |